Article
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
13 Feb 2023
Abstract excerpt
Multiple myeloma (MM) is a highly refractory hematologic cancer. Targeted immunotherapy has shown promise in MM but remains hindered by the challenge of identifying specific yet broadly representative tumor markers. We analyzed 53 bone marrow (BM) aspirates from 41 MM patients using an unbiased, high-throughput pipeline for therapeutic target discovery via single-cell transcriptomic profiling, yielding 38 MM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
